Hong Kong, 17 March 2026 — WuXi XDC Cayman Inc. (stock code 02268, “WuXi XDC”, acting as the Offeror) has secured valid acceptances for 463,672,734 shares of BioDlink International Company Limited (stock code 01875, “BioDlink-B”), representing exactly 60.00 % of BioDlink-B’s issued share capital and voting rights. The acceptance level satisfies the threshold set in the composite offer and response document dated 12 February 2026, rendering the voluntary conditional cash offer for BioDlink-B’s shares unconditional in all respects.

In parallel, 6,512,600 outstanding share options—equivalent to 85.33 % of BioDlink-B’s total options—have been tendered for cancellation under the accompanying option offer. Because the share offer is now fully unconditional, the option offer has likewise become unconditional.

Key timetable • Offers remain open for acceptance until 4:00 p.m. on 31 March 2026 (“Final Closing Date”). • Cheques for valid acceptances lodged on or before the Final Closing Date will be despatched no later than 14 April 2026. • Settlement of consideration, in cash, will be completed within seven business days after (i) receipt of a valid acceptance or (ii) 17 March 2026, whichever is later.

Other terms of the offers, as detailed in the Composite Document and accompanying Forms of Acceptance, remain unchanged. Shareholders, restricted share award (RSA) holders and option holders are advised to review the Composite Document and seek professional advice if in doubt.

The Offeror and its concert parties held no BioDlink-B shares or options prior to the offer period and have not engaged in any share borrowing or lending transactions during the period.

Market participants are reminded to exercise caution when dealing in BioDlink-B securities until completion of the offer process.